With what RedHawk is doing right now, 100 million in revenues are very possible. What does it take to get 15 million in tax losses to carry forward.
When the EU License Acquisition is complete, RedHawk Pharma will own approximately 120 generic EU licensing assets and have approximately $15,000,000 of tax loss carryforwards available to offset future profits in the United Kingdom. The Company said it believes this new alliance with IPG will better position RedHawk Pharma to successfully integrate EcoGen and the EU License Acquisition, manage the anticipated growth of this business unit, and enhance the probability of successfully completing other organic and strategic business opportunities in the future.